Most Recent
Construction PRO
Leases and certain other land acquisitions will be exempt from the new mandatory merger control regime, in changes announced this week following feedback arising out of the transitional, voluntary phase.
The Victorian Supreme Court has granted cosmetic surgeon Daniel Lanzer an extension to provide discovery in a class action against him and his clinic after hearing he was facing medical issues.
Construction PRO
The competition regulator is seeking to intervene in Mayfield Development's appeal to the High Court in a case the developer says could have "startling" consequences.
Construction PRO
Corrs Chambers Westgarth has advised the Sunshine Coast Airport on financing to support its ambitious terminal expansion project.
Construction PRO
A judge has largely given the go-ahead to Buildcorp Group's proposed amendments to cross-claims as trial gets under way in a case over aluminium cladding at Star Entertainment's Sydney casino.
Construction PRO
Brookfield Properties has admitted that it failed to follow procedures on consultation and redeployment when it made a senior manager redundant when she was on parental leave.
Construction PRO
The High Court has approved the imposition of additional land tax on non-residents and foreign-owned entities, finding that the Commonwealth government had the power to limit the application of international tax agreements.
Construction PRO
Realside Rundle Square wants a preliminary question on a term in its lease heard first in a suit against M3Property and a valuer alleging tenants of Adelaide's Rundle Mall in Adelaide have been overcharged for rent since 2006 due to valuation flaws.
The Queensland government has introduced defamation reforms to bring it in line with other jurisdictions and prevent “forum shopping,” adding a new defence for social media platforms and increasing powers for courts.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.